Hedeker Wealth LLC acquired a new stake in Stericycle Inc. (NASDAQ:SRCL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 4,924 shares of the company’s stock, valued at approximately $512,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Meeder Asset Management Inc. purchased a new stake in shares of Stericycle during the second quarter valued at about $155,000. Canada Pension Plan Investment Board raised its stake in shares of Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares in the last quarter. Trust Co. of Vermont raised its stake in shares of Stericycle by 70.9% in the second quarter. Trust Co. of Vermont now owns 1,784 shares of the company’s stock valued at $186,000 after buying an additional 740 shares in the last quarter. Jones Financial Companies Lllp purchased a new stake in shares of Stericycle during the first quarter valued at about $203,000. Finally, Charter Trust Co. purchased a new stake in shares of Stericycle during the second quarter valued at about $203,000. 92.72% of the stock is owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded up 1.47% during trading on Friday, reaching $75.47. The company’s stock had a trading volume of 977,443 shares. The firm’s 50-day moving average price is $80.45 and its 200 day moving average price is $98.03. The company has a market capitalization of $6.42 billion, a P/E ratio of 26.56 and a beta of 0.20. Stericycle Inc. has a 12-month low of $72.89 and a 12-month high of $151.57.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.18. The firm earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The company’s quarterly revenue was up 24.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 EPS. On average, analysts predict that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
Several brokerages have issued reports on SRCL. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating in a research note on Tuesday, June 28th. Jefferies Group reissued a “buy” rating and set a $140.00 price objective on shares of Stericycle in a research note on Monday, July 18th. Wellington Shields lowered Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Imperial Capital lowered Stericycle from an “in-line” rating to an “underperform” rating and dropped their price objective for the company from $100.00 to $93.50 in a research note on Friday, July 29th. Finally, Barrington Research reissued an “outperform” rating and set a $88.00 price objective (down previously from $100.00) on shares of Stericycle in a research note on Wednesday, October 5th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $103.54.
In other news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the transaction, the director now owns 10,188 shares in the company, valued at approximately $871,074. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by insiders.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.